SCHEMBL622334

SCHEMBL622334

CC(=O)C(Br)c1ccc(Cl)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 1/20 0.59
HDAC4 P56524 1/20 0.44
HDAC7 Q8WUI4 1/20 0.44
HDAC5 Q9UQL6 1/20 0.44
FFAR2 O15552 2/20 0.43
ADRB2 P07550 1/20 0.41
CYP2C9 P11712 3/20 0.41
MEN1 O00255 2/20 0.41
CYP2D6 P10635 2/20 0.41
CYP2C19 P33261 2/20 0.41
KMT2A Q03164 2/20 0.41
CES2 O00748 2/20 0.40
CES1 P23141 2/20 0.40
SLC6A4 P31645 1/20 0.40
SLC6A3 Q01959 1/20 0.40
GABBR2 O75899 3/20 0.39
GABBR1 Q9UBS5 3/20 0.39
LMNA P02545 2/20 0.39
CYP3A4 P08684 1/20 0.39
ADORA3 P0DMS8 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8551228 0.89 BRD4 (0.49) BRD4
SCHEMBL5463742 0.84 CYP2C9 (0.44) BRD4CYP2C9MEN1CYP2D6KMT2A
SCHEMBL5742269 0.80 CES2 (0.46) BRD4HDAC4HDAC7HDAC5FFAR2
SCHEMBL9298515 0.80 BRD4 (0.45) BRD4HDAC4HDAC7HDAC5FFAR2
SCHEMBL16601483 0.80 ESR1 (0.50) BRD4CYP2C9MEN1CYP2D6CYP2C19
SCHEMBL9298853 0.80 CES2 (0.52) BRD4HDAC4HDAC7HDAC5CYP2C9
SCHEMBL75753 0.80 CES2 (0.52) BRD4HDAC4HDAC7HDAC5CYP2C9
SCHEMBL5559079 0.80 CYP1A2 (0.55) CYP2C19CES2CES1NFKB1CNR1
SCHEMBL75858 0.80 BRD4 (0.45) BRD4HDAC4HDAC7HDAC5FFAR2
SCHEMBL22445731 0.78 BRD4 (0.39) BRD4MEN1KMT2ACES2CES1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-7011195-A None JP disclosed
EP-2603214-A1 HETEROARYLS AND USES THEREOF Millennium Pharmaceuticals, Inc. (US) 2013-06-19 EP disclosed
WO-2012021696-A1 HETEROARYLS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2012-02-16 WO disclosed
EP-2173743-A2 SODIUM CHANNEL INHIBITORS Icagen, Inc. (US) 2010-04-14 EP disclosed
WO-2009012242-A2 SODIUM CHANNEL INHIBITORS ICAGEN, INC. (US) 2009-01-22 WO disclosed
JP-H0711195-A WAX TAJIMA INC 1995-01-13 JP disclosed